Equities
  • Price (USD)695.94
  • Today's Change18.96 / 2.80%
  • Shares traded690.46k
  • 1 Year change+135.01%
  • Beta1.6868
Data delayed at least 15 minutes, as of Jul 30 2021 20:30 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.

  • Revenue in USD (TTM)3.47bn
  • Net income in USD698.45m
  • Incorporated1997
  • Employees18.07k
  • Location
    Align Technology Inc410 NORTH SCOTTSDALE ROAD, SUITE 1300TEMPE 85281United StatesUSA
  • Phone+1 (408) 470-1000
  • Fax+1 (408) 470-1010
  • Websitehttp://www.aligntech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
West Pharmaceutical Services Inc.2.52bn519.20m29.89bn9.20k59.18--48.9211.856.846.8433.22--------274,184.80--11.01--13.0139.3533.2819.6712.68--55.92--18.3316.698.9343.2429.355.797.63
Zimmer Biomet Holdings Inc7.09bn567.70m33.93bn20.00k59.972.7320.974.792.712.7134.0359.720.28620.86745.86354,405.002.301.152.611.2969.5670.658.033.821.194.510.386466.54-12.003.21-112.27---1.161.76
Baxter International Inc12.20bn1.12bn38.91bn50.00k35.484.5519.533.192.182.1823.7416.990.62313.716.25243,940.005.7810.836.8913.3139.5741.889.2717.191.7812.870.419520.452.743.2136.5622.90-4.89-5.54
ResMed Inc.3.09bn457.24m39.25bn7.77k86.3314.4963.7412.703.123.1221.1718.620.67963.075.62397,820.6010.0512.6211.9314.7558.1657.7114.7918.461.1220.720.212545.4413.4411.9951.4111.998.056.85
DexCom, Inc.2.03bn514.00m44.10bn5.50k87.9523.1774.8821.765.195.1920.5119.680.59282.965.45368,472.7015.035.7817.456.7868.4366.0925.367.985.224.030.4780.0030.5436.81388.23--42.98--
Align Technology, Inc.3.47bn698.45m53.57bn18.07k77.1515.8393.4015.428.778.7743.6642.770.73755.775.42192,265.8014.8329.3220.5942.4474.2773.2820.1033.471.21----0.002.7123.93301.0865.2723.72--
Boston Scientific Corporation11.20bn526.00m64.40bn38.00k123.23--41.685.750.36780.36787.83--------294,657.90--3.03--3.7866.4569.705.217.17------0.00-7.665.80-119.23--0.3484--
Edwards Lifesciences Corp4.47bn851.00m69.39bn14.90k83.4714.9071.8215.511.341.347.097.490.67331.557.64300,281.9012.8114.6914.4917.4875.2274.5119.0221.522.88--0.11330.000.880911.96-21.5610.7230.77--
Becton Dickinson and Co18.86bn1.64bn74.25bn72.00k45.442.9919.353.945.625.6264.7285.370.34793.508.82261,958.303.162.433.642.7747.2046.949.106.781.326.970.416580.41-1.0010.73-25.681.995.055.66
Data as of Jul 30 2021. Currency figures normalised to Align Technology Inc's reporting currency: US Dollar USD

Institutional shareholders

35.53%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 20216.28m7.94%
Edgewood Management LLCas of 31 Mar 20214.50m5.69%
BlackRock Fund Advisorsas of 31 Mar 20213.96m5.00%
SSgA Funds Management, Inc.as of 31 Mar 20212.86m3.62%
Sands Capital Management LLCas of 31 Mar 20212.86m3.61%
AllianceBernstein LPas of 31 Mar 20211.62m2.05%
Polen Capital Management LLCas of 31 Mar 20211.56m1.98%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 20211.56m1.97%
Wellington Management Co. LLPas of 31 Mar 20211.53m1.93%
JPMorgan Investment Management, Inc.as of 31 Mar 20211.38m1.75%
More ▼
Data from 31 Mar 2021 - 31 Mar 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.